Protective Factors against Fear of Cancer Recurrence in Breast Cancer Patients: A Latent Growth Model.
BOUNCE
breast cancer
coping self-efficacy
fear of cancer recurrence
latent growth modeling
trajectories
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
08
08
2023
revised:
03
09
2023
accepted:
11
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The current study aimed to examine the fear of cancer recurrence (FCR) trajectory and protective predictors in women coping with breast cancer (BC). The study's model investigated whether a higher coping self-efficacy and positive cognitive-emotion regulation at the time of the BC diagnosis would lead to reduced levels of FCR at six months and in later stages (12 and 18 months) post-diagnosis. The sample included 494 women with stages I to III BC from Finland, Italy, Portugal, and Israel. They completed self-report questionnaires, including the Fear of Cancer Recurrence Inventory (FCRI-SF), the Cancer Behavior Inventory-Brief Version (CBI-B), the Cognitive-Emotion Regulation Questionnaire (CERQ short), and medical-social-demographic data. Findings revealed that a higher coping self-efficacy at diagnosis predicted lower FCR levels after six months but did not impact the FCR trajectory over time. Surprisingly, positive cognitive-emotion regulation did not predict FCR levels or changes over 18 months. FCR levels remained stable from six to 18 months post-diagnosis. This study emphasizes the importance of developing specific cancer coping skills, such as coping self-efficacy. Enhancing coping self-efficacy in the first six months after BC diagnosis may lead to lower FCR levels later, as FCR tends to persist in the following year.
Identifiants
pubmed: 37760558
pii: cancers15184590
doi: 10.3390/cancers15184590
pmc: PMC10526521
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Union's Horizon 2020 Research and Innovation Programme
ID : 777167
Organisme : Canadian Friends of the Hebrew University (CFHU) Fellowship Fund
Références
Psychooncology. 2022 Jun;31(6):879-892
pubmed: 35388525
Oncol Nurs Forum. 2012 May 1;39(3):287-95
pubmed: 22543387
J Cancer Surviv. 2015 Mar;9(1):68-79
pubmed: 25135205
Psychooncology. 2007 Mar;16(3):171-80
pubmed: 16858670
J Transcult Nurs. 2019 Mar;30(2):146-153
pubmed: 29708040
Psychooncology. 2007 Apr;16(4):329-41
pubmed: 16888704
Psychooncology. 2021 Sep;30(9):1555-1562
pubmed: 33998100
Support Care Cancer. 2016 Oct;24(10):4207-18
pubmed: 27169700
Cancer Res Treat. 2022 Oct;54(4):1065-1073
pubmed: 34883553
Singapore Med J. 2021 Jun;62(6):305-310
pubmed: 31989183
Clin Psychol Rev. 2019 Mar;68:13-24
pubmed: 30617013
J Psychosom Res. 2023 Mar;166:111177
pubmed: 36739729
BMC Cancer. 2018 Oct 20;18(1):1002
pubmed: 30342495
Int J Environ Res Public Health. 2022 Sep 30;19(19):
pubmed: 36231811
Psychotherapy (Chic). 2022 Jun;59(2):261-270
pubmed: 34990161
Sci Rep. 2014 Jul 04;4:5569
pubmed: 24993798
Cancer J. 2008 Nov-Dec;14(6):369-74
pubmed: 19060601
Front Psychol. 2020 Nov 02;11:580979
pubmed: 33224072
Front Psychol. 2021 Jun 09;12:647432
pubmed: 34177701
Eur J Cancer Care (Engl). 2008 Mar;17(2):157-66
pubmed: 18302653
Psychol Health. 2019 Jan;34(1):44-63
pubmed: 30516396
Front Psychiatry. 2022 Jun 16;13:859604
pubmed: 35782420
J Natl Cancer Inst. 2021 Nov 2;113(11):1495-1505
pubmed: 34057469
Acta Oncol. 2017 Feb;56(2):314-320
pubmed: 28093034
Support Care Cancer. 2022 Mar;30(3):2829-2837
pubmed: 34845503
Psychooncology. 2013 May;22(5):978-86
pubmed: 22674873
Am Psychol. 1989 Mar;44(3):513-24
pubmed: 2648906
Support Care Cancer. 2014 Mar;22(3):705-12
pubmed: 24193220
J Psychosoc Oncol. 2020 Mar-Apr;38(2):156-170
pubmed: 31625826
Psychooncology. 1997 Jun;6(2):95-105
pubmed: 9205967
Cancer Nurs. 2022 Sep-Oct 01;45(5):406-415
pubmed: 34560707
Psychooncology. 2013 Jan;22(1):1-11
pubmed: 22232030
Oncotarget. 2017 May 30;8(22):36800-36811
pubmed: 28404938
Eur J Cancer Care (Engl). 2019 Sep;28(5):e13113
pubmed: 31180170
Cancer Med. 2018 Oct;7(10):4980-4992
pubmed: 30187678
Psychooncology. 2011 Mar;20(3):302-12
pubmed: 20878830
Clin J Oncol Nurs. 2016 Dec 1;20(6):E155-E161
pubmed: 27857253
J Sch Psychol. 2010 Feb;48(1):5-37
pubmed: 20006986
J Psychosom Res. 2013 Apr;74(4):354-60
pubmed: 23497839
J Clin Oncol. 2009 Dec 20;27(36):6172-9
pubmed: 19884548
Psychooncology. 2018 Jan;27(1):295-301
pubmed: 28727897
Psychooncology. 2019 Oct;28(10):2033-2041
pubmed: 31364222
Cancer. 2022 Jan 15;128(2):335-343
pubmed: 34614212
J Cancer Surviv. 2013 Sep;7(3):300-22
pubmed: 23475398
Psychooncology. 2017 Oct;26(10):1444-1454
pubmed: 27246348
Integr Cancer Ther. 2016 Jun;15(2):175-82
pubmed: 26420778
Health Psychol. 2016 Jan;35(1):1-9
pubmed: 26030308
Clin Breast Cancer. 2019 Jun;19(3):165-177
pubmed: 30952546
Psychol Assess. 2018 Apr;30(4):486-499
pubmed: 28504538
Support Care Cancer. 2016 Aug;24(8):3265-8
pubmed: 27169703
Gynecol Oncol. 2007 Feb;104(2):381-9
pubmed: 17027072
Am J Transl Res. 2022 Jul 15;14(7):4804-4811
pubmed: 35958474
BMC Cancer. 2022 Apr 15;22(1):414
pubmed: 35428224
Health Psychol. 2016 Dec;35(12):1329-1333
pubmed: 27175578
Breast Care (Basel). 2019 Dec;14(6):344-353
pubmed: 31933579
J Pain Symptom Manage. 2020 Aug;60(2):381-389
pubmed: 32105790
Sch Inq Nurs Pract. 2001 Fall;15(3):277-94
pubmed: 11871585
Psychooncology. 2020 Nov;29(11):1835-1841
pubmed: 32720375
Psychooncology. 2009 Jan;18(1):71-8
pubmed: 18613299
Body Image. 2018 Dec;27:21-31
pubmed: 30121489
Psychooncology. 2012 Feb;21(2):203-10
pubmed: 22271541
Psychooncology. 2019 Sep;28(9):1781-1790
pubmed: 31206917
Support Care Cancer. 2009 Mar;17(3):241-51
pubmed: 18414902
Support Care Cancer. 2015 Jul;23(7):2033-43
pubmed: 25524004